Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12456232 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol
Condition: Coronary Heart Disease
Interventions: Drug: gemfibrozil;   Other: Placebo

Indicates status has not been verified in more than two years